BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 10716687)

  • 1. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.
    Muratori L; Parola M; Ripalti A; Robino G; Muratori P; Bellomo G; Carini R; Lenzi M; Landini MP; Albano E; Bianchi FB
    Gut; 2000 Apr; 46(4):553-61. PubMed ID: 10716687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sera of children with hepatitis C infection and anti-liver-kidney microsome-1 antibodies recognize different CYP2D6 epitopes than adults with LKM+/HCV+ sera.
    Herzog D; Yamamoto AM; Jara P; Maggiore G; Sarles J; Alvarez F
    J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):551-5. PubMed ID: 10554122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes.
    Yamamoto AM; Mura C; De Lemos-Chiarandini C; Krishnamoorthy R; Alvarez F
    Clin Exp Immunol; 1993 Jun; 92(3):381-90. PubMed ID: 7685669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection.
    Ma Y; Gregorio G; Gäken J; Muratori L; Bianchi FB; Mieli-Vergani G; Vergani D
    J Hepatol; 1997 Jun; 26(6):1396-402. PubMed ID: 9210629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.
    Klein R; Zanger UM; Berg T; Hopf U; Berg PA
    Clin Exp Immunol; 1999 Nov; 118(2):290-7. PubMed ID: 10540193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.
    Kerkar N; Choudhuri K; Ma Y; Mahmoud A; Bogdanos DP; Muratori L; Bianchi F; Williams R; Mieli-Vergani G; Vergani D
    J Immunol; 2003 Feb; 170(3):1481-9. PubMed ID: 12538711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis.
    Muratori L; Cataleta M; Muratori P; Lenzi M; Bianchi FB
    Gut; 1998 May; 42(5):721-6. PubMed ID: 9659171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule.
    Ma Y; Thomas MG; Okamoto M; Bogdanos DP; Nagl S; Kerkar N; Lopes AR; Muratori L; Lenzi M; Bianchi FB; Mieli-Vergani G; Vergani D
    J Immunol; 2002 Jul; 169(1):277-85. PubMed ID: 12077255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel assay for detecting antibodies to cytochrome P4502D6, the molecular target of liver kidney microsomal antibody type 1.
    Kerkar N; Ma Y; Hussain M; Muratori L; Targett C; Williams R; Bianchi FB; Mieli-Vergani G; Vergani D
    J Immunol Methods; 1999 Mar; 223(2):227-35. PubMed ID: 10089101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children.
    Bortolotti F; Muratori L; Jara P; Hierro L; Verucchi G; Giacchino R; Barbera C; Zancan L; Guido M; Resti M; Pedditzi S; Bianchi F; Gatta A
    J Pediatr; 2003 Feb; 142(2):185-90. PubMed ID: 12584542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon therapy in LKM-1 positive patients with chronic hepatitis C: follow-up by a quantitative radioligand assay for CYP2D6 antibody detection.
    Duclos-Vallée JC; Nishioka M; Hosomi N; Arima K; Leclercq A; Bach JF; Yamamoto AM
    J Hepatol; 1998 Jun; 28(6):965-70. PubMed ID: 9672171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?
    Marceau G; Lapierre P; Béland K; Soudeyns H; Alvarez F
    Hepatology; 2005 Sep; 42(3):675-82. PubMed ID: 16037945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis.
    Choudhuri K; Gregorio GV; Mieli-Vergani G; Vergani D
    Hepatology; 1998 Nov; 28(5):1177-81. PubMed ID: 9794898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.
    Muratori L; Lenzi M; Ma Y; Cataleta M; Mieli-Vergani G; Vergani D; Bianchi FB
    Gut; 1995 Sep; 37(3):406-12. PubMed ID: 7590439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.
    Hintermann E; Holdener M; Bayer M; Loges S; Pfeilschifter JM; Granier C; Manns MP; Christen U
    J Autoimmun; 2011 Nov; 37(3):242-53. PubMed ID: 21795021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.
    Sugimura T; Obermayer-Straub P; Kayser A; Braun S; Loges S; Alex B; Lüttig B; Johnson EF; Manns MP; Strassburg CP
    Autoimmunity; 2002 Dec; 35(8):501-13. PubMed ID: 12765476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece.
    Dalekos GN; Makri E; Loges S; Obermayer-Straub P; Zachou K; Tsikrikas T; Schmidt E; Papadamou G; Manns MP
    Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):35-42. PubMed ID: 11782573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type-2 (AIH-2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay.
    Yamamoto AM; Johanet C; Duclos-Vallee JC; Bustarret FA; Alvarez F; Homberg JC; Bach JF
    Clin Exp Immunol; 1997 Jun; 108(3):396-400. PubMed ID: 9182882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients.
    Kitazawa E; Igarashi T; Kawaguchi N; Matsushima H; Kawashima Y; Hankins RW; Miyakawa H
    J Autoimmun; 2001 Nov; 17(3):243-9. PubMed ID: 11712862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C.
    Miyakawa H; Kitazawa E; Kikuchi K; Fujikawa H; Kawaguchi N; Abe K; Matsushita M; Matsushima H; Igarashi T; Hankins RW; Kako M
    Autoimmunity; 2000; 33(1):23-32. PubMed ID: 11204250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.